FLASH NEWS LIVE

U.S. FDA changes course and agrees to review Moderna's mRNA flu vaccine application

U.S. FDA changes course and agrees to review Moderna's mRNA flu vaccine application

Moderna says the U.S. Food and Drug Administration (FDA) has agreed to review its influenza ‌vaccine, reversing an earlier decision to reject the application, following modifications from the company.

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.